T1	PrimaryOutcome 10 49	Reductions of C reactive protein levels
T2	TimeFrame 50 84	at day 5 and 8 after randomization
R1	MeasuredAt Arg1:T1 Arg2:T2	
T3	SecondaryOutcome 145 161	admission to ICU
T4	TimeFrame 162 202	within 15 and 30 days from randomization
R2	MeasuredAt Arg1:T3 Arg2:T4	
T5	SecondaryOutcome 204 240	occurrence of mechanical ventilation
T6	TimeFrame 241 281	within 15 and 30 days from randomization
R3	MeasuredAt Arg1:T5 Arg2:T6	
T7	SecondaryOutcome 283 288	death
T8	TimeFrame 289 329	within 15 and 30 days from randomization
R4	MeasuredAt Arg1:T7 Arg2:T8	
T9	SecondaryOutcome 331 404	composite occurrence of admission to ICU, mechanical ventilation or death
T10	TimeFrame 405 445	within 15 and 30 days from randomization
R5	MeasuredAt Arg1:T9 Arg2:T10	
T11	SecondaryOutcome 447 499	proportion of patients requiring supplemental oxygen
T12	TimeFrame 500 509	at day 15
R6	MeasuredAt Arg1:T11 Arg2:T12	
T13	SecondaryOutcome 582 618	time from randomization to discharge
T14	TimeFrame 619 650	up to day 15 from randomization
R7	MeasuredAt Arg1:T13 Arg2:T14	
T15	SecondaryOutcome 656 719	significative differences in serum lactate dehydrogenase levels
T16	TimeFrame 720 735	at day 5 and 8.
R8	MeasuredAt Arg1:T15 Arg2:T16	
